Collplant Biotechnologies Ltd (CLGN) — Cash Flow Reinvestment Rate

Latest as of September 2023: 0.07x

Collplant Biotechnologies Ltd (CLGN) has a Cash Flow Reinvestment Rate of 0.07x as of September 2023, reinvesting $486.00K (capex $243.00K plus investments $-243.00K) from operating cash flow of $6.78 Million. See free cash flow generation of Collplant Biotechnologies Ltd to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.07x
(Capex + Investments) / Operating CF

Total Reinvested

$486.00K
Capex + Investments

Operating Cash Flow

$6.78 Million
USD

Capital Expenditures

$243.00K
USD

Collplant Biotechnologies Ltd Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Collplant Biotechnologies Ltd across 1 annual periods. For the full cash flow conversion analysis, see CLGN operating cash flow.

Annual Cash Flow Reinvestment Rate for Collplant Biotechnologies Ltd (2021–2021)

Year-by-year capital reinvestment analysis for Collplant Biotechnologies Ltd. See Collplant Biotechnologies Ltd (CLGN) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 12.57x $31.43 Million $2.50 Million $1.43 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow